1. Park JY, Park K, Jeong SJ. History of Investigative and Clinical Urology and an analysis of published articles. Investig Clin Urol. 2020; 61:Suppl 1. S64–S69.
Article
2. Parker DC, Cookson MS. The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer. Investig Clin Urol. 2020; 61:Suppl 1. S3–S7.
Article
3. Kim J, Kim WT, Kim WJ. Advances in urinary biomarker discovery in urological research. Investig Clin Urol. 2020; 61:Suppl 1. S8–S22.
Article
4. Asghar AM, Lee RA, Yang KK, Metro M, Eun DD. Robot-assisted distal ureteral reconstruction for benign pathology: Current state. Investig Clin Urol. 2020; 61:Suppl 1. S23–S32.
Article
5. Chen JL, Kuo HC. Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis. Investig Clin Urol. 2020; 61:Suppl 1. S33–S42.
Article
6. Sha S, Ni L, Stefil M, Dixon M, Mouraviev V. The human gastrointestinal microbiota and prostate cancer development and treatment. Investig Clin Urol. 2020; 61:Suppl 1. S43–S50.
Article
7. Andolfi C, Gundeti MS. Live-case demonstrations in pediatric urology: ethics, patient safety, and clinical outcomes from an 8-year institutional experience. Investig Clin Urol. 2020; 61:Suppl 1. S51–S56.
Article
8. Blau EK, Adelstein SA, Amin KA, Durfy SJ, Lucioni A, Kobashi KC, et al. Tobacco use, immunosuppressive, chronic pain, and psychiatric conditions are prevalent in women with symptomatic mesh complications undergoing mesh removal surgery. Investig Clin Urol. 2020; 61:Suppl 1. S57–S63.
Article